Crescent Biopharma Announces Grants of Inducement Awards
Crescent Biopharma granted inducement options to purchase an aggregate of 81,525 shares to six non-executive employees under its 2025 Employment Inducement Incentive Award Plan. The options carry a 10-year term with an exercise price of $13.94, matching the October 5, 2026 Nasdaq closing price, and vest 1/4th at the first employment anniversary with monthly vesting thereafter.
Key figures
- Recipients
- 6
- Exercise price
- 13.94
- Option term years
- 10
- Inducement options shares
- 81525
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.